- Presentation-Password Protected-PLEASE NOTE ignore the opening comments as these relate to the live webinar, of which this is a recorded version. Allow time for the presentation to buffer and download. Also you will sign in differently with this activity, Password only!
In this knowledge-based continuing pharmacy education activity Dr Rodrick Marriott, PharmD, discusses recent law changes, as well as updates to State of Connecticut Medical Marijuana Program and the pharmacy inspection program.
Pharmacists who are interested in the laws affecting Pharmacists in the State of Connecticut.
This activity is not accredited for technicians.
At the conclusion of the activity, pharmacists will be able to:
- Discuss the current state of the Connecticut Medical Marijuana Program
- Discuss the emerging role of pharmacists in helping to prevent opioid overdose deaths
- Discuss areas examined in a pharmacy inspection and common citations issued
- Review recent law changes which affect pharmacy practice
Rodrick Marriott, Pharm.D.
Director, Drug Control Division
Department of Consumer Protection
State of Connecticut
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Rodrick Marriott, PharmD, has no actual or potential conflicts of interest associated with this presentation.
Click on the registration link to register for this activity. The cost is $15.00.
This activity has no funding.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hour (0.1 CEU) will be awarded to pharmacists who submit the assessment successfully with a passing grade of 70% and complete the evaluation. (ACPE #0009-0000-16-069-H03-P). Credits will be electronically transmitted to CPE Monitor within 72 hours of completing the activity.
Initial release date: December 16, 2016
Planned expiration date: December 16, 2019
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.